{"id":2721,"date":"2019-09-02T10:28:35","date_gmt":"2019-09-02T08:28:35","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/uncategorized\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/"},"modified":"2022-06-17T09:28:42","modified_gmt":"2022-06-17T07:28:42","slug":"blockchain-in-focus-new-column-by-andreas-helget-is-online","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/","title":{"rendered":"Blockchain in focus &#8211; New column by Andreas Helget is online"},"content":{"rendered":"<p>Enthusiasts acclaim it as a tremendous opportunity for empowerment while skeptics ask the iconoclastic question \u201cSo where\u2019s the problem that\u2019s been lacking for this solution?\u201d. And several commentators have referred to it as a revolution. We\u2019re talking here about <strong>blockchains<\/strong>.<\/p>\n<h3>Yet what are blockchains, what exactly do they do and what makes the technology so revolutionary?<\/h3>\n<p>The blockchain concept can hardly be described as new. People have been negotiating trust ever since they started negotiating with one another in the first place. However, such trust is only rarely blind \u2013 on the contrary, it is usually protected with the best possible safeguards. \u201cBlockchains\u201d have arguably been around since the Middle Ages, when two or more individuals carved notches in a piece of wood after reaching an agreement. The number of notches indicated the amount of the debt, payments made or goods changing hands. The stick, or \u201ctally\u201d, was then split lengthwise and each party to the transaction received one half \u2013 a technique that was deemed to be tamper proof.<\/p>\n<h3>Bank as a &#8220;middleman&#8221;<\/h3>\n<p><img decoding=\"async\" class=\" wp-image-10300 alignleft\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_83347305-scaled.jpeg\" alt=\"\" width=\"551\" height=\"270\" \/>When two people do business with one another today, a bank is generally involved as an intermediary: the provider receives the payment due to him or her when money flows from one current account to another. In practice, the bank\u2019s role in this transaction is only minor \u2013 it simply acts as the \u201cmiddleman\u201d between two individuals to ensure that there is no breach of trust when the money is handed over.<\/p>\n<h3>As far as the business itself is concerned, notaries are totally irrelevant<\/h3>\n<p>A notary tends to be called in whenever the objects to be negotiated are more complex. As far as the business itself is concerned, notaries are totally irrelevant; their sole purpose is to record (\u201cnotarize\u201d) the legal act. In doing so, they ensure that mutual trust is maintained between all parties.<\/p>\n<h3>A blockchain resembles an open book<\/h3>\n<p>Blockchains are now set to take on this role. A blockchain resembles an open book \u2013 a public ledger based on distributed ledger technology (DLT). The only difference is that it\u2019s digital. It consists of a chain of blocks made up of records. The ledger\u2019s special feature is that every block contains a full copy (\u201chash\u201d) of the previous block, so that as the number of blocks increases each one not only gets bigger but also more difficult to tamper with. It is impossible to change a past block without changing all of the following blocks. Any attempt to tamper with the blockchain will be immediately noticed \u2013 just as it would with a tally \u2013 except that in this case, the tally is distributed across umpteen different computers. <em>Instead of a tally stick that is split in order to establish a contract between two people, blockchains store a track on as many entities as possible to <a href=\"https:\/\/www.nzz.ch\/feuilleton\/blockchain-geld-kerbholz-das-neolithikum-erklaert-das-kapital-ld.1443274\">prevent tracks (blocks) from being added or deleted<\/a>.<\/em> Like the system \u201cbank\u201d or the person \u201cnotary\u201d, the construct \u201cblockchain\u201d is designed to build trust.<\/p>\n<h3>Trustful relationship<\/h3>\n<p>If a block also contains executable code, we use the term \u201csmart contract\u201d. This is a transaction which is automatically executed once the specified conditions are met. For instance, when a house buyer requests an entry in the land register, a sum of money previously deposited with the notary is transferred. A smart contract includes this process from the outset: defined actions are carried out as soon as defined conditions are satisfied. Not even for the logical continuation of the process is an entity necessary.<\/p>\n<h3>Reliability of information<\/h3>\n<p>The partners collaborating here could be business people. However, devices or systems can just as easily work in this way. Many of the familiar elements in the process industry presuppose <em>reliability<\/em> of information, in other words a \u201ctrustful relationship\u201d between the devices and systems concerned. This raises exciting, fundamental questions for the future. \u201cIs a machine allowed to <em>own a wallet<\/em>?\u201d, for example. Imagine a driverless car that needs to fill up with gas. Does it then make its way to the fuel dispenser or the charging point and pay using <em>its own money<\/em>? Digital wallets and distributed payment technologies are logical continuations which have been <a href=\"https:\/\/ngin-mobility.com\/artikel\/zf-ubs-innogy-blockchain\/\">under discussion<\/a> for vehicles for some time now.<\/p>\n<figure id=\"attachment_10291\" aria-describedby=\"caption-attachment-10291\" style=\"width: 612px\" class=\"wp-caption alignleft\"><img decoding=\"async\" class=\" wp-image-10291\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_271208426-scaled.jpeg\" alt=\"\" width=\"612\" height=\"343\" \/><figcaption id=\"caption-attachment-10291\" class=\"wp-caption-text\">Blockchain technology on blue background &#8211; 3D Rendering<\/figcaption><\/figure>\n<h3>Blockchains can also be used \u201cas a service\u201d<\/h3>\n<p>A number of providers such as Deloitte, SAP or IBM already exist. Blockchains as a service are not at all complicated: a set of data, say from a pharmaceutical manufacturing plant, is sent to the service provider\u2019s blockchain at a defined time. The sender receives a record (block) in return. The blockchain, which grows in size from one transaction to the next, is secured either for life or for a defined time period, so that it is possible to demonstrate at any time that specific values applied at a particular instant during pharmaceutical production.<\/p>\n<h3>New technology<\/h3>\n<p>Excessive blockchain growth unfortunately remains a structural handicap of the new technology, which is mainly suited at present for low-frequency transactions. If a sensor is queried a hundred times per second, the technology is definitely not yet a viable option. However, if that sensor only supplies one temperature value every ten minutes, it could be validated today using a blockchain without any problem.<\/p>\n<h3>Revolution and influence<\/h3>\n<p>Blockchain technology undoubtedly has the potential to start a revolution and influence the patterns of daily life. It can take the place of all institutions which only exist because they (purport to) build trust. Notaries and banks, to name but two. A single platform. And absolutely anything to do with currencies. If you hand a hundred dollar bill to someone, that person trusts that slip of paper to be strong and worth the same tomorrow as it is today. And although Germany has experienced several monetary devaluations in the past, we Germans still have considerable trust in our currency.<\/p>\n<h3>Founded on trust<\/h3>\n<p>All provisions we make for the future or for when we retire are founded on this trust. Cryptocurrencies try to establish a similar degree of trust \u2013 and very successfully too \u2013 albeit using different mechanisms. The enormous power of traditional \u201ctrusters\u201d \u2013 the banker\u2019s banks immediately spring to mind here \u2013 is beginning to be challenged. It\u2019s a scenario that is bound to appear threatening to those directly affected.<\/p>\n<h3>The end of platforms as we know them?<\/h3>\n<p>Trust building nowadays frequently takes place on everyone\u2019s favorite platforms \u2013 Amazon, Ebay and PayPal are particularly popular. And in the end a bank, too, is nothing more than a platform. Yet if you could buy something direct from a stranger devoid of all risk \u2013 and if compliance with contracts of any kind could be automatically verified \u2013 then you wouldn\u2019t actually need a platform at all. Public ledgers could mean the end of platforms as we know them. It is this that ultimately what gives the idea its subversive character: the fact that middlemen and gatekeepers will to a large extent be eliminated, from banks through governments to portals. And it is this potential that makes blockchain technology so revolutionary.<\/p>\n<h3>Destructive revolutions challenge the status quo<\/h3>\n<p>Yet blockchains are likely to feel a strong headwind, especially \u2013 though not only \u2013 from financial regulators. And the technology itself is (still) dogged by problems on several different fronts.<\/p>\n<p>There are destructive revolutions that challenge the status quo. And there are productive revolutions that explore new paths and render the status quo superfluous. What do you think? How will blockchains change the world we live in?<\/p>\n<hr \/>\n<blockquote class=\"wp-embedded-content\" data-secret=\"MWyNQKN1uE\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/for-the-first-time-as-a-video-new-column-by-dr-andreas-helget-is-online\/\">For the first time as a video: New column by Dr. Andreas Helget is online<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;For the first time as a video: New column by Dr. Andreas Helget is online&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/for-the-first-time-as-a-video-new-column-by-dr-andreas-helget-is-online\/embed\/#?secret=0RVyp1hK9R#?secret=MWyNQKN1uE\" data-secret=\"MWyNQKN1uE\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"N44Nj7GPSM\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/third-column-of-dr-andreas-helget\/\">Third column of Dr. Andreas Helget<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Third column of Dr. Andreas Helget&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/automation-en\/third-column-of-dr-andreas-helget\/embed\/#?secret=MWNUEYktF2#?secret=N44Nj7GPSM\" data-secret=\"N44Nj7GPSM\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"sFVPpm0Vfj\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/uncategorized\/first-column-of-helget\/\">First Column of Dr. Helget<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;First Column of Dr. Helget&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/uncategorized\/first-column-of-helget\/embed\/#?secret=Mbqa9MoI5S#?secret=sFVPpm0Vfj\" data-secret=\"sFVPpm0Vfj\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In his latest column Dr. Andreas Helget, Managing Director of Yokogawa Deutschland GmbH, deals with the subject of blockchain. What potential does this possibly revolutionary idea offer? And why is the blockchain still a headwind? <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\"> <span class=\"screen-reader-text\">Blockchain in focus &#8211; New column by Andreas Helget is online<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":103,"featured_media":6943,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[53],"tags":[490,519,455,621,651,652,560,524,547,653,654,655,444,656,657],"coauthors":[79],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Blockchain in focus - New column by Andreas Helget is online - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blockchain in focus - New column by Andreas Helget is online\" \/>\n<meta property=\"og:description\" content=\"In his latest column Dr. Andreas Helget, Managing Director of Yokogawa Deutschland GmbH, deals with the subject of blockchain. What potential does this possibly revolutionary idea offer? And why is the blockchain still a headwind?  Blockchain in focus &#8211; New column by Andreas Helget is online Read More &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-02T08:28:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-17T07:28:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1275\" \/>\n\t<meta property=\"og:image:height\" content=\"679\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Andreas Helget\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\"},\"author\":{\"name\":\"Andreas Helget\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525\"},\"headline\":\"Blockchain in focus &#8211; New column by Andreas Helget is online\",\"datePublished\":\"2019-09-02T08:28:35+00:00\",\"dateModified\":\"2022-06-17T07:28:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\"},\"wordCount\":1295,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"keywords\":[\"Amazon\",\"Blockchain\",\"Column\",\"Deloitte\",\"Dr. Andreas Helget\",\"Ebay\",\"Helget\",\"IBM\",\"Industrial Process Monitoring\",\"opinion\",\"Paypal\",\"pharamceutical production\",\"process\",\"SAP\",\"Technology\"],\"articleSection\":[\"Automation\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\",\"name\":\"Blockchain in focus - New column by Andreas Helget is online - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\"},\"datePublished\":\"2019-09-02T08:28:35+00:00\",\"dateModified\":\"2022-06-17T07:28:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blockchain in focus &#8211; New column by Andreas Helget is online\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Yokogawa&#039;s Chemical &amp; Pharma Blog\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525\",\"name\":\"Andreas Helget\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/d11ce512bca58d005c116bcae861b383\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg\",\"caption\":\"Andreas Helget\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/helget\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Blockchain in focus - New column by Andreas Helget is online - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/","og_locale":"en_US","og_type":"article","og_title":"Blockchain in focus - New column by Andreas Helget is online","og_description":"In his latest column Dr. Andreas Helget, Managing Director of Yokogawa Deutschland GmbH, deals with the subject of blockchain. What potential does this possibly revolutionary idea offer? And why is the blockchain still a headwind?  Blockchain in focus &#8211; New column by Andreas Helget is online Read More &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2019-09-02T08:28:35+00:00","article_modified_time":"2022-06-17T07:28:42+00:00","og_image":[{"width":1275,"height":679,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video.jpg","type":"image\/jpeg"}],"author":"Andreas Helget","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/"},"author":{"name":"Andreas Helget","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525"},"headline":"Blockchain in focus &#8211; New column by Andreas Helget is online","datePublished":"2019-09-02T08:28:35+00:00","dateModified":"2022-06-17T07:28:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/"},"wordCount":1295,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"keywords":["Amazon","Blockchain","Column","Deloitte","Dr. Andreas Helget","Ebay","Helget","IBM","Industrial Process Monitoring","opinion","Paypal","pharamceutical production","process","SAP","Technology"],"articleSection":["Automation"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/","name":"Blockchain in focus - New column by Andreas Helget is online - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website"},"datePublished":"2019-09-02T08:28:35+00:00","dateModified":"2022-06-17T07:28:42+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/blockchain-in-focus-new-column-by-andreas-helget-is-online\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/"},{"@type":"ListItem","position":2,"name":"Blockchain in focus &#8211; New column by Andreas Helget is online"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","name":"Chemical Pharma Blog","description":"Yokogawa&#039;s Chemical &amp; Pharma Blog","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525","name":"Andreas Helget","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/d11ce512bca58d005c116bcae861b383","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg","caption":"Andreas Helget"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/helget\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video.jpg",1275,679,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video-300x160.jpg",300,160,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video-768x409.jpg",768,409,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video-1024x545.jpg",1024,545,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video.jpg",1275,679,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video.jpg",1275,679,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/HelgetKolumne-Video-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Andreas Helget","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/helget\/"},"uagb_comment_info":0,"uagb_excerpt":"In his latest column Dr. Andreas Helget, Managing Director of Yokogawa Deutschland GmbH, deals with the subject of blockchain. What potential does this possibly revolutionary idea offer? And why is the blockchain still a headwind? Blockchain in focus &#8211; New column by Andreas Helget is online Read More &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/2721"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/users\/103"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/comments?post=2721"}],"version-history":[{"count":2,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/2721\/revisions"}],"predecessor-version":[{"id":11144,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/2721\/revisions\/11144"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media\/6943"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media?parent=2721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/categories?post=2721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/tags?post=2721"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/coauthors?post=2721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}